John Trezino
Chief Operating Officer
Replay available
Novavax, Inc. (NASDAQ: NVAX) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Chief Operating Officer
Analyst, B. Riley Securities
Analyst, Jefferies
Analyst, ED Securities
Vice President, Investor Relations
Head of R&D
Chief Financial Officer and Treasurer
President and CEO
Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.218 Good morning and welcome to Novavax First Quarter 2025 Financial Results 00:00:05.218 -- 00:00:08.222 and Operational Highlights Conference Call. 00:00:08.222 -- 00:00:11.407 All participants will be in listen-only mode. 00:00:11.407 -- 00:00:15.793 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.793 -- 00:00:21.080 key followed by zero. After today's presentation, there will be an opportunity 00:00:21.080 -- 00:00:23.163 to ask questions. 00:00:23.163 -- 00:00:27.436 To ask a question, you may press star followed by the number one on your title. 00:00:27.436 -- 00:00:32.762 on phone. To withdraw your question, please press star followed by the number two. 00:00:32.762 -- 00:00:35.766 Please note, this event is being recorded. 00:00:35.766 -- 00:00:40.111 I would now like to turn the conference over to Luis Sanay, Vice President, Investor 00:00:40.111 -- 00:00:43.255 Relations. Please go ahead. 00:00:43.255 -- 00:00:47.761 Good morning and thank you all for joining us today to discuss our first quarter 2025 00:00:47.761 -- 00:00:51.645 financial results and operational highlights. 00:00:51.645 -- 00:00:57.237 A press release announcing our results is currently available on our website at novavax.com 00:00:57.237 -- 00:01:03.246 and an audio archive of this conference call will be available on our website later today. 00:01:03.246 -- 00:01:08.374 Please turn to slide two. Before we begin with prepared remarks, I need to 00:01:08.374 -- 00:01:12.941 remind you that this presentation includes forward-looking statements, including but 00:01:12.941 -- 00:01:18.809 not limited to statements related to Novavax's corporate strategy and operating plans, 00:01:18.809 -- 00:01:24.057 its strateg...